COMBINATION OF PSILOCYBIN AND COGNITIVE BEHAVIORAL THERAPY IMPROVES OXYTOCIN LEVELS AND DEPRESSIVE SYMPTOMS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER. Genetics and Molecular Research, [S. l.], 2026. DOI: 10.4238/e91xh631. Disponível em: https://geneticsmr.com/index.php/gmr/article/view/598.. Acesso em: 8 may. 2026.